Gene Expression Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Gene Expression stocks.

Gene Expression Stocks Recent News

Date Stock Title
Jun 2 A Salesforce And Celsius Were Among The 10 Biggest Large Cap Losers Last Week: Are These In Your Portfolio?
May 31 A Is It Time To Consider Buying Agilent Technologies, Inc. (NYSE:A)?
May 30 CSTL Castle Biosciences to Present New Data at 2024 ASCO® Annual Meeting Highlighting Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Metastasis to the Central Nervous System to Prompt Use of Imaging Surveillance
May 30 A Agilent (A) Q2 Earnings Beat Estimates, Revenues Fall Y/Y
May 30 A These Stocks Are Moving the Most Today: Salesforce, UiPath, Kohl’s, Foot Locker, Agilent, C3.ai, HP Inc., and More
May 30 CDNA AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress
May 30 A Q2 2024 Agilent Technologies Inc Earnings Call
May 30 A Salesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise
May 30 IVA Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
May 30 IVA Statement of total voting rights and shares forming the company’s share capital as of May 13, 2024
May 30 A Agilent Technologies, Inc. (A) Q2 2024 Earnings Call Transcript
May 29 A Agilent (A) Reports Q2 Earnings: What Key Metrics Have to Say
May 29 A Agilent Technologies (A) Surpasses Q2 Earnings Estimates
May 29 A Agilent Technologies Stock Sinks After Company Cuts Guidance To Reflect Slower Market Recovery
May 29 A Agilent down 14% following revised 2024 guidance
May 29 A Agilent Technologies Fiscal Q2 Non-GAAP Earnings, Revenue Fall; Full Year Guidance Cut -- Shares Down After Hours
May 29 CSTL New Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis
May 29 A Agilent Technologies Non-GAAP EPS of $1.22 beats by $0.03, revenue of $1.57B misses by $10M
May 29 A Agilent Reports Second-Quarter Fiscal Year 2024 Financial Results
May 29 VCYT Wall Street Analysts Think Veracyte (VCYT) Could Surge 39.07%: Read This Before Placing a Bet
Gene Expression

Gene expression is the process by which information from a gene is used in the synthesis of a functional gene product. These products are often proteins, but in non-protein coding genes such as transfer RNA (tRNA) or small nuclear RNA (snRNA) genes, the product is a functional RNA.
The process of gene expression is used by all known life—eukaryotes (including multicellular organisms), prokaryotes (bacteria and archaea), and utilized by viruses—to generate the macromolecular machinery for life.
Several steps in the gene expression process may be modulated, including the transcription, RNA splicing, translation, and post-translational modification of a protein. Gene regulation gives the cell control over structure and function, and is the basis for cellular differentiation, morphogenesis and the versatility and adaptability of any organism. Gene regulation may also serve as a substrate for evolutionary change, since control of the timing, location, and amount of gene expression can have a profound effect on the functions (actions) of the gene in a cell or in a multicellular organism.
In genetics, gene expression is the most fundamental level at which the genotype gives rise to the phenotype, i.e. observable trait. The genetic code stored in DNA is "interpreted" by gene expression, and the properties of the expression give rise to the organism's phenotype. Such phenotypes are often expressed by the synthesis of proteins that control the organism's shape, or that act as enzymes catalysing specific metabolic pathways characterising the organism. Regulation of gene expression is thus critical to an organism's development.

Browse All Tags